AI Verdict
QRVO has stronger fundamentals based on our AI analysis.
QRVO vs OTLC Fundamental Comparison
| Metric | QRVO | OTLC |
|---|---|---|
| Revenue | $2.9B | $70,000.0 |
| Net Income | $309.3M | $-1.1M |
| Net Margin | 10.8% | -1,526.0% |
| ROE | 8.4% | -11.8% |
| ROA | 5.0% | -3.8% |
| Current Ratio | 3.67x | 0.08x |
| Debt/Equity | 0.42x | 0.14x |
| EPS | $3.30 | $0.00 |
Green = Better metric | Red = Weaker metric
You Might Also Compare
QRVO vs OTLC: Frequently Asked Questions
Is QRVO or OTLC a better buy in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), QRVO has stronger fundamentals. QRVO is rated BUY (72% confidence) while OTLC is rated STRONG SELL (95% confidence). This is not investment advice.
How does QRVO compare to OTLC fundamentally?
Qorvo, Inc. has ROE of 8.4% vs Oncotelic Therapeutics, Inc.'s -11.8%. Net margins are 10.8% vs -1,526.0% respectively.
Which stock pays higher dividends, QRVO or OTLC?
QRVO has a dividend yield of N/A or no dividend while OTLC has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in QRVO or OTLC for long term?
For long-term investing, consider that QRVO has BUY rating with 72% confidence, while OTLC has STRONG SELL rating with 95% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about QRVO vs OTLC?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For QRVO vs OTLC, the AI consensus favors QRVO based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.